Isosilybin B TN1805
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediated pathway, it has anti-prostate cancer (PCA) activity that is mediated via cell cycle arrest and apoptosis induction. Isosilybin B showed inhibito
CAS nr:
142796-22-3
Purity:
98%
Molecular Weight:
482,4
SMILES:
COc(cc([C@@H]1Oc(ccc([C@H]([C@H](C2=O)O)Oc3c2c(O)cc(O)c3)c2)c2O[C@H]1CO)cc1)c1O
Formula:
C25H22O10
Pathway:
PI3K/Akt/mTOR signaling,Apoptosis,Cytoskeletal Signaling,PI3K/Akt/mTOR signaling
Target:
PI3K,Mdm2,Akt,Akt
